New Times,
New Thinking.

  1. Culture
  2. Books
10 February 2018updated 28 Jun 2021 4:39am

The Beautiful Cure: The lethal complexity of our immune systems

How immunology – the study of the immune system – went from a marginal area of clinical medicine to a health revolution.

By Henry Marsh

When I was a medical student 40 years ago, immunology – the study of how our bodies fight infection – was a rather marginal area of clinical medicine. Frank MacFarlane Burnet and Peter Medawar had shared the Nobel prize in 1960 for their work on immunological tolerance, which laid the foundations of our understanding of why transplanted organs were rejected. The discovery of immunosuppressive drugs (in particular cyclosporin in the 1970s) made transplant surgery possible, and autoimmune diseases (such as rheumatoid arthritis and Crohn’s) – illnesses where our immune systems attack our own bodies rather than just alien infections or transplants – had first been described in the 1960s. Nevertheless, relatively little was understood about the immune system and clinical immunology was not considered to be an important or prestigious area of medical practice. Nor was it thought that the immune system could “see” cancer cells, and the idea that it might be enhanced and harnessed to treat the condition was seen as little short of quackery.

How things change! Daniel M Davis’s wonderful book The Beautiful Cure recounts how research into the immune system in recent decades has resulted in what amounts to a health revolution. Immunotherapy drugs are now worth billions of dollars, and cancers and autoimmune diseases that were once considered untreatable can now be fought and, in a few cases, even cured. There is little doubt that there will be further progress in the years to come.

Subscribe to The New Statesman today from only £8.99 per month
Content from our partners
The role and purpose of social housing continues to evolve
More than a landlord: A future of opportunity
Towards an NHS fit for the future